{"id":109446,"date":"2021-06-01T06:44:02","date_gmt":"2021-06-01T06:44:02","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=109446"},"modified":"2021-06-01T06:45:18","modified_gmt":"2021-06-01T06:45:18","slug":"wyburn-mason-syndrome","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/","title":{"rendered":"Wyburn-Mason syndrome"},"content":{"rendered":"<p>Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-109446","post","type-post","status-publish","format-standard","hentry","category-w"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome<\/title>\n<meta name=\"description\" content=\"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome\" \/>\n<meta property=\"og:description\" content=\"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-01T06:44:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-01T06:45:18+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/\",\"name\":\"Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-06-01T06:44:02+00:00\",\"dateModified\":\"2021-06-01T06:45:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wyburn-Mason syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome","description":"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome","og_description":"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/","og_site_name":"Glossary","article_published_time":"2021-06-01T06:44:02+00:00","article_modified_time":"2021-06-01T06:45:18+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/","name":"Wyburn-Mason syndrome - Definition of Wyburn-Mason syndrome","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-06-01T06:44:02+00:00","dateModified":"2021-06-01T06:45:18+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Wyburn-Mason syndrome, also known as Bonnet- Dechaume-BIanc syndrome, is a rare condition that is characterized by arteriovenous malformations (i.e., abnormal communication between the arteries and veins) in the central nervous system and the retina. These malformations take the form of arteriovenous aneurysms, which are widenings of the walls of an artery and a vein with abnormal blood flow between the vessels. This condition is considered to be congenital, and it is passed on via autosomal dominant inheritance, which means that an affected person has a 50% chance of passing the trait to a child. In 1937, Bonnet et al. recognized the coexistence of retinal and cerebral arteriovenous malformations (AVMs). In 1943, Wyburn-Mason recorded cases of arteriovenous malformations of the midbrain, retina, and facial nevi and found that this syndrome may also be associated with mental changes in some cases.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/wyburn-mason-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Wyburn-Mason syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=109446"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109446\/revisions"}],"predecessor-version":[{"id":109447,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109446\/revisions\/109447"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=109446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=109446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=109446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}